Literature DB >> 8119516

[Pulmonary hypertension and systemic sclerosis].

S Morelli1, P De Marzio, G Valesini, M S Bonavita.   

Abstract

BACKGROUND: Pulmonary involvement in systemic sclerosis (SS) is a frequent complication and is associated with a poor prognosis. Pulmonary hypertension may or may not develop, however, its recognition is usually possible only in advanced stages.
METHODS: In this study we noninvasively evaluated the pulmonary artery systolic pressure in 31 patients with SS using Doppler echocardiography. Pulmonary hypertension was detected in 48.4% of the patients.
RESULTS: The prevalence of pulmonary hypertension was similar in patients with limited SS and diffuse SS (42.9% and 52.9%, respectively; p = NS). No differences were observed in pulmonary artery systolic pressure between patients with limited or diffuse SS and pulmonary hypertension. Pulmonary hypertension was usually mild, and only in two cases was pulmonary systolic pressure higher than 50 mmHg (63 and 107 mmHg, respectively).
CONCLUSIONS: Pulmonary hypertension is frequently observed in patients with SS. The patients with diffuse or limited SS are equally affected by this complication. Doppler echocardiography has proved to be the technique of choice for the evaluation of pulmonary involvement in patients with SS because it is noninvasive, inexpensive and allows serial examinations. Early recognition of pulmonary hypertension may favor the use of therapeutical strategies to prevent the progression to advanced forms.

Entities:  

Mesh:

Year:  1993        PMID: 8119516

Source DB:  PubMed          Journal:  G Ital Cardiol        ISSN: 0046-5968


  2 in total

1.  Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension.

Authors:  S Morelli; C Ferri; L Di Francesco; R Baldoncini; M Carlesimo; U Bottoni; G Properzi; A Santucci
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

2.  Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.

Authors:  Michał Ciurzyński; Piotr Bienias; Barbara Lichodziejewska; Katarzyna Kurnicka; Agnieszka Szewczyk; Maria Glińska-Wielochowska; Marcin Kurzyna; Maria Błaszczyk; Danuta Liszewska-Pfejfer; Piotr Pruszczyk
Journal:  Clin Rheumatol       Date:  2008-02-07       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.